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ABSTRACT
Objective: N-acetylcysteine is an antioxidant with thiol/sulfhydryl groups and is currently being developed as an active ingredient in anti-aging 
creams. The study’s aim was to compare the stability and antioxidant activity of N-acetylcysteine in anti-aging creams formulated with and without 
a transfersome carrier system.
Methods: Stability was assessed by performing cycling, centrifugal, and accelerated stability tests. In addition, antioxidant activity was measured 
by the DPPH method, and in vitro penetration was measured using Franz diffusion cells. The analysis of N-acetylcysteine was performed using high-
performance liquid chromatography with ultraviolet–visible detection at a wavelength of 214 nm and a flow rate of 1.0 mL/min, injection volume of 
5 µL, and a mobile phase of phosphate buffer pH 3.0.
Results: The N-acetylcysteine transfersome and non-transfersome cream preparations did not change color or show phase separation during the 
cycling and centrifugal tests. The N-acetylcysteine in the transfersome and non-transfersome cream preparations had strong antioxidant activity, 
with half-maximal inhibitory concentrations of 26.90 µg/mL and 38.63 µg/mL, respectively. The in vitro penetration test using Franz diffusion cells 
showed that the cumulative amount of penetrated N-acetylcysteine was 7355.13 µg/cm2 (flux of 845.67 µg/cm2∙h) in the transfersome cream and 
4677.61 µg/cm2 (flux of 533.33 µg/cm2∙h) in the non-transfersome cream.
Conclusion: The in vitro penetration test results showed that the transfersome formulations in creams were able to increase the cumulative amount 
and flux of penetrated N-acetylcysteine in anti-aging cream preparations relative to those not formulated with transfersome.
Keywords: N-acetylcysteine, Transfersome, Anti-aging, Stability, Antioxidant, High-performance liquid chromatography.
INTRODUCTION
Signs of aging can be partly prevented and slowed using various 
methods, one of which is the application of cosmetics. Cosmetics that 
are currently widely used to mask or slow signs of aging of the skin 
are called anti-aging cosmetics. Anti-aging products on the market are 
available in various dosage forms, one of which is a cream. Creams 
are generally preferred as topical dosage forms because cream is 
easily applied and easily removed from the skin [1]. Anti-aging cream 
products available on the market generally use an antioxidant as the 
active ingredient. Antioxidants are simple molecules that can prevent 
cell damage caused by oxidation stimulated by other molecules [2]. An 
antioxidant that has recently been developed as an active ingredient in 
anti-aging creams is N-acetylcysteine.
N-acetylcysteine is an antioxidant derived from the amino acid 
L-cysteine. N-acetylcysteine contains thiol/sulfhydryl (R-SH/-SH) 
groups, which are antioxidants [3]. N-acetylcysteine can prevent and/
or inhibit the oxidative process as measured by different biomarkers of 
oxidative stress [4]. N-acetylcysteine can act as a direct antioxidant and 
indirect antioxidant. The mechanism of direct antioxidation involves a 
free thiol group that can interact directly with electrons from reactive 
oxygen species. In addition, N-acetylcysteine also can act as an indirect 
antioxidant because it can undergo deacetylation to cysteine, which 
is an intracellular reduced glutathione precursor that can increase 
glutathione levels in the body [3,4].
N-acetylcysteine is not stable under oxidative conditions because it is 
easily oxidized when formulated. Stabilization strategies are needed 
to maintain the stability of N-acetylcysteine formulations for use as 
antioxidative anti-aging creams. One strategy to maintain the stability 
of N-acetylcysteine is to formulate it with a transfersome carrying 
system [5]. The study’s aim was to test the effects of transfersome 




The following instrumentation was used: High-performance liquid 
chromatography (HPLC) (Model LC-20AT; Shimadzu, Japan); rotary 
vacuum evaporator (Buchi, Switzerland); ultraviolet (UV)–visible 
spectrophotometer (Shimadzu UV-1601 and Jasco Climate Chamber; 
Nuve Sanayi Malzemeleri Imalat ve Tic. A.S., Turki); vortex mixer 
(Thermo Scientific, America); centrifuge (Hettich Centrifugen EBA 200); 
microcentrifuge (Thermo Fisher Scientific); sonicator (Branson 3200); 
particle size analyzer (Malvern Zetasizer, Inggris); oven (Memmert); 
refrigerator (GEA, Germany); and Franz diffusion cell.
Materials
N-acetylcysteine standard (Daebong LS Co. LTD., Korea Selatan); 
phosphatidylcholine (Merck, Germany); Tween 80 (Merck); 
potassium dihydrogen phosphate (Merck, Germany); phosphoric 
acid (Merck); sodium hydroxide (Merck); sodium metabisulfite 
(Merck); dichloromethane p.a (Merck); distilled water (Ikapharmindo 
Putramas); and methanol (Merck) were used.
Preparation of mobile phase potassium dihydrogen phosphate 
pH 3.0
A 6.8 g amount of potassium dihydrogen phosphate was dissolved in 
1000 mL of distilled water, adjusted with phosphoric acid to a pH 3.0, 
filtered, and degassed.
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Preparation of sodium metabisulfite solution
A 0.25 g amount of sodium metabisulfite was dissolved in 500 mL of 
distilled water, freshly prepared [6].
Preparation of N-acetylcysteine 400 µg/mL standard solution
A 100 mg amount of N-acetylcysteine standard was accurately weighed 
and placed in a 10 mL volumetric flask, dissolved, and made up to 
volume with sodium metabisulfite solution to give a standard stock 
solution of 10.000 µg/mL. The standard stock solution was then 
diluted to a concentration of 1000 µg/mL and diluted again to give a 
concentration of 400 µg/mL [6].
Determination of optimum analysis conditions
The following general chromatographic conditions were used to 
analyze N-acetylcysteine: Shimpack C18 column (5 µm, 4.6×250 mm), 
sodium metabisulfite solution as solvent, potassium dihydrogen 
phosphate solution pH 3.0 as mobile phase, injection volume of 5 µL, 
and detection wavelength of 214 nm. The optimum analysis conditions 
were determined by varying the flow rate at 0.8, 1.0, and 1.2 mL/min. 
The standard N-acetylcysteine 400 µg/mL test solution was injected 
(≤5 µL) into the HPLC. The selected optimized chromatographic 
conditions were those that gave the highest peak area, a relatively 
short retention time (tR), the largest number of theoretical plates (N), 
the smallest height equivalent to a theoretical plate (HETP; the best 
potential separation efficiency), and the smallest tailing factor (Tf).
System suitability test
A 5 µL aliquot of the standard solution of N-acetylcysteine 
(400 µg/mL) was injected 6 times into the HPLC under the optimum 
analysis conditions. The peak area, tR, N, HETP value, resolution (R), 
and Tf were determined and averaged. The results were obtained at the 
optimum wavelength and analysis conditions. The results fulfilled the 
system suitability test requirements of coefficient of variation (CV) <2%.
Validation of HPLC method
Linearity, limit of detection (LOD), and limit of quantitation (LOQ)
A standard solution of N-acetylcysteine (1000 µg/mL) was diluted 
to give 100, 200, 300, 400, 500, and 600 µg/mL working solutions. 
Then, 5 µL of a working solution was injected into the HPLC under 
the optimum analysis conditions [6]. A calibration curve was created 
from the peak area (y) versus the concentration of analyte (x). A linear 
regression equation and the correlation coefficient for the fitted curve 
were determined. Based on the calibration curve obtained, the LOD and 
LOQ were calculated. The results fulfilled linearity requirements, with a 
correlation coefficient r>0.9990.
Selectivity test
A blank solution (cream matrix) and standard solution of 
N-acetylcysteine 400 µg/mL were prepared. A 5 µL aliquot of the 
blank and standard solutions were separately injected into the HPLC 
under the optimum analysis conditions. The results of the blank and 
standard selectivity test chromatograms were compared, and the 
chromatograms were evaluated to determine if there was interference 
or the appearance of another peak around the tR of N-acetylcysteine. 
Selectivity was assessed to be good if there was no interference and no 
other peaks around the N-acetylcysteine tR.
Accuracy and precision
Accuracy and precision were determined using a simulation method 
(spiked-placebo recovery), which involved adding a number of 
pure material analytes to the carrier material for pharmaceutical 
preparations (placebo). Then, the mixture was analyzed under the 
optimum analysis conditions, and the results were compared with the 
analyte levels added (actual levels). The concentration used in the test 
of accuracy and precision of N-acetylcysteine was 50% (200 µg/mL), 
100% (400 µg/mL), and 150% (600 µg/mL) [7]. The 50% concentration 
was made by mixing 20 mg of N-acetylcysteine standard into a 
500 mg cream matrix. The 100% concentration was made by mixing 
40 mg of N-acetylcysteine standard into a 500 mg cream matrix. The 
concentration of 150% was made by mixing 60 mg of N-acetylcysteine 
standard into a 500 mg cream matrix. For each of these concentrations, 
the sample was accurately weighed and dissolved in 10 mL of sodium 
metabisulfite solution in a volumetric flask. The solution of each 
concentration was sonicated for 30 min and vortex mixed for 5 min, 
then centrifuged at 4000 rpm for 15 min. The supernatants from each 
concentration were filtered through 0.45 µm nylon syringe filters, and 
then 5 µL were injected into the HPLC under the optimum analysis 
conditions. The 50% and 150% concentrations were analyzed with 
triplicate injections, and the 100% concentration was analyzed with 6 
injections.
Each concentration was injected into the HPLC under the optimum 
analysis conditions and the peak area of N-acetylcysteine was integrated 
and recorded. The percent recovery (%UPK) was calculated by 
comparing the measured concentration with the actual concentration. 
Acceptable accuracy was a %UPK ranging from 98% to 102%. Precision 
was determined as the relative standard deviation or CV. Acceptable 
precision was a CV <2% [8].
Transfersome formulation
Transfersome formulations were prepared by a thin-layer hydration 
method. The transfersome formulations are presented in Table 1. 
Transfersome was formulated by mixing phosphatidylcholine and 
Tween 80 and dissolving them in dichloromethane. The solution 
was then placed in a round-bottom flask and evaporated on a 
rotary vacuum evaporator for 60 min at a temperature of 40°C and 
50–150 rpm. Nitrogen gas was passed over the thin residual layer 
for 2 min, and the flask was then stored in a refrigerator for 24 h in 
a closed state. The thin layer was hydrated with a phosphate buffer 
solution (pH 7.4) containing N-acetylcysteine in a rotary vacuum 
evaporator at a temperature of 30°C and rotation speed of 50–150 rpm 
for 60 min with glass beads to remove the thin layer on the round flask 
wall. Ultrasonication was performed for 10 min to reduce the particle 
size of the solids [7,9-11].
Transfersome optimization
Particle size and polydispersity index
Determination of the particle size and polydispersity index of the 
transfersome formulations were determined by the dynamic light 
scattering method using a particle size analyzer at 25°C. One drop of 
sample from each transfersome formulation was dispersed in 10.0 mL 
of distilled water and then tested for particle size.
Entrapment efficiency
Entrapment efficiency was measured by calculating the total and 
released N-acetylcysteine concentrations in a transfersome suspension. 
The released concentration of N-acetylcysteine measurement was 
obtained by dissolving 1 mL of transfersome suspension in 10 mL of 
sodium metabisulfite solution and then centrifuging at 13,000 rpm for 
2 hat 4°C. The supernatant was filtered and injected into the HPLC.
Transfersome and non-transfersome cream preparations
The optimum transfersome suspension was freeze-dried. A dry 
transfersome suspension equivalent to 5% N-acetylcysteine 
was added gradually into the cream base and then mixed by 
using a homogenizer at 500 rpm. In a non-transfersome cream, 
N-acetylcysteine was added at 5% into the cream base and mixed 
using a homogenizer at 500 rpm.
Table 1: Mobile phase selection






N-acetylcysteine 1.5 1.5 1.5
Phosphatidylcholine 1.35 1.275 1.125
Tween 80 0.15 0.225 0.375
Phosphate buffer solution pH 7.4 12 12 12
Total 15 15 15
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Stability tests
Cycling test
The two cream samples were stored at 4°C for 24 h and then transferred 
to an oven at 40°C±2°C for 24 h, which constituted one cycle. Six 
more cycles were performed over 12 days. The physical conditions of 
creams, such as organoleptic characteristics (discoloration, odor, and 
homogeneity), were observed before and after the experiment.
Centrifugal test
Both cream samples were inserted into the centrifugation tube and 
then centrifuged at 3750 rpm for 5 h. After centrifugation, the sample 
was observed to determine if phase separation between the water and 
oil phases occurred.
Accelerated stability testing
Both cream samples were stored in a climate chamber with storage 
conditions of 40°C±2°C and relative humidity of 70%±5% RH for 
3 months. Sampling was carried out at 0, 1, 2, and 3 months and 
analyzed using HPLC under optimum analysis conditions.
Approximately 80 mg of each stability test sample was accurately 
weighed and dissolved in 10 mL with sodium metabisulfite solution in 
a volumetric flask. The sample solution was sonicated for 30 min and 
vortex mixed for 5 min, then centrifuged at 4000 rpm for 15 min. The 
supernatant of each sample was filtered and injected into the HPLC 
under the optimum analysis conditions. This procedure was performed 
in triplicate for each sample.
Antioxidant activity test using DPPH assay
Approximately 250 mg of each cream sample (containing 12.5 mg 
N-acetylcysteine) was weighed accurately and placed into a 25.0 mL 
volumetric flask, dissolved, and made up to volume with methanol. 
The sample solution was then sonicated for 10 min and centrifuged 
at 4000 rpm for 10 min. The supernatant of each sample was filtered, 
and a 500 µg/mL sample stock solution was obtained. The sample 
stock solution was then diluted to a concentration of 100 µg/mL and 
diluted again to obtain sample concentrations of 1, 5, 10, 15, 20, and 
30 µg/mL. A 3.0 mL aliquot of diphenyl picrylhydrazyl (DPPH) was 
added to 1.0 mL of each sample solution. Methanol (1.0 mL) and DPPH 
50 µg/mL (3.0 mL) solutions were used as a blank. The mixture was 
shaken for 20 s and incubated in a dark room at room temperature 
(27°C±2°C) for 30 min.
The antioxidant activity was determined by measuring the absorbance 
of each sample by UV–visible spectrophotometry at an optimum 
wavelength of 515 nm. The result obtained was used to calculate the 
inhibition percentage of DPPH by N-acetylcysteine in cream samples. 
The percentage of DPPH radical inhibition was calculated by comparing 
the sample and blank results.
Franz diffusion cells in vitro penetration test
The membrane used was the abdomen skin of 2–3-month-old female 
Sprague-Dawley rats weighing 150–200 g. In this study, all methods 
for sacrificing the animals had been approved through an ethical 
approval certificate from the Health Research Ethics Committee, 
Faculty of Medicine, University of Indonesia No.184/UN2.F1/ETIK/
PPM.00.02/2019. In vitro penetration tests were performed using Franz 
diffusion cells with a diffusion area of 1.77 cm2 and a compartment 
volume of 15.0 mL. The receptor compartment was filled with ≤15.0 mL 
phosphate-buffered solution pH 7.4 and the temperature was maintained 
using a water jacket at 37°C±0.5°C and stirred with a magnetic stirrer at 
a speed of 200 rpm. The abdominal skin was shaved and cleaned of fat 
and then placed between the donor and receptor compartments with 
the position of the stratum corneum facing up. The cream samples 
tested in this study were 5% N-acetylcysteine transfersome cream and 
5% N-acetylcysteine non-transfersome cream. Each cream sample (1 g) 
was applied to the skin in the donor compartment. Sample solution 
(1 mL) was taken from the receptor compartment using a syringe at 10, 
30, 60, 90, 120, 180, 240, 300, 360, 420, and 480 min and immediately 
refilled with the same amount of phosphate buffer pH 7.4. The sample 
solution was inserted into a vial, and its concentration was measured by 
HPLC under the optimum analysis conditions.
RESULTS AND DISCUSSION
Determination of optimum analysis conditions
The results of the analysis method optimization are presented in 
Table 2.
The flow rate chosen in this study was 1.0 mL/min because it gave 
better results than those at the flow rate of 0.8 mL/min and 1.2 mL/min. 
The flow rate of 1.0 mL/min had a large peak area of 1,130,622 µV/s, 
the retention time of 8.718 min was relatively early, and the Tf of 1.446 
was the smallest of the tested conditions. The flow rate of 0.8 mL/min 
was not chosen even though it had a larger peak area than that at 
1.0 mL/min because the retention time of 11.236 min was too long and 
the Tf was higher.
System suitability test
The system suitability test results are presented in Table 3.
The system suitability test was performed first before analysis under the 
optimum analysis conditions. After injecting the 400 µg/mL standard 
Table 2: Peak area, retention time, tailing factor, column efficiency, and theoretical plates from N-acetylcysteine chromatograms at two 
eluent flow rates
Flow rate (mL/min) Peak area (µV/s) Retention time (min) Tailing factor HETP (cm) Theoretical plates (N)
0.8 1,470,303 11.236 1.516 40.187 3733
1.0 1,130,622 8.718 1.446 41.683 3599
1.2 9,59,846 7.436 1.454 44.133 3399
Table 3: System suitability test results of N-acetylcysteine








1,144,078 8.980 1.469 41.758 3592
1,147,670 8.979 1.500 42.551 3525
400 1,150,640 8.718 1.479 41.826 3586
1,141,042 8.642 1.498 41.558 3690
1,155,160 8.686 1.495 40.543 3700
1,149,613 8.620 1.454 41.596 3606
Average 1,148,033.83 8.771 1.483 41.639 3617
Standard deviation 4994.6942 0.1652 0.0185 0.6466 66.9141
Coefficient of variation (%) 0.44 1.88 1.25 1.55 1.85
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solution of N-acetylcysteine 6 times, the coefficients of variation were 
0.44% for peak area, 1.88% for retention time, 1.25% for Tf, 1.55% for 
HETP, and 1.85% for the number of theoretical plates (N). The CV did 
not exceed 2%, as required [8].
Validation method
Linearity, LOD, and LOQ
The calibration curve data, LOD, and LOQ of N-acetylcysteine are 
presented in Table 4.
Fig. 1 shows the calibration curve for N-acetylcysteine. The results 
obtained are excellent because they have a correlation coefficient close 
to 1 (r>0.9990) [8]. The LOD and LOQ values were sufficiently sensitive.
Selectivity test
The chromatogram from the blank solution did not show any interference 
or peaks of other compounds at the retention time of N-acetylcysteine, 
which supports the selectivity of the method for N-acetylcysteine [8].
Accuracy and precision
The accuracy and precision of the method are presented in Table 5.
The precision fulfilled the requirements by giving a CV of ≤2% [8]. The 
method used in this study fulfilled the criteria for accuracy and precision.
Transfersome formulation optimization
The transfersome formulation optimization results are presented in 
Table 6.
Particle size
The Z-average value shows the average particle size in the preparation. 
The particle sizes were good and were <200 nm [12]. The results show 
that higher concentrations of surfactant gave larger particle size [13].
Polydispersity index
The particle size distribution is reflected by the polydispersity 
index parameter and is used to show the particle size distribution 
in nanoparticle systems. The polydispersity index values ranged 
from 0 to 0.6. If the value is >0.6, the sample has a very wide size 
distribution; as the value approaches zero, the particle size distribution 
is increasingly homogeneous. The resulting values were good because 
they were <0.6 [12]. The results showed that the distribution of particle 
size in F1 was the most homogeneous. The polydispersity index of each 
formula increased with increasing particle size [14].
Entrapment efficiency
Determination of entrapment efficiency was performed to determine 
the amount of active substances that were absorbed by transfersome. 
The highest entrapment efficiency was 65.58% for F1. The entrapment 
efficiency of transfersome increased with increasing lipid concentration 
(phospholipid) and decreased with increasing surfactant concentration 
because lower surfactant concentrations (<15%, b/b) allowed all 
surfactant molecules to bind to the phospholipid bilayer layer. If 
the concentration exceeds a certain concentration, some surfactant 
molecules will cause an increase in the permeability of the vesicle 
membrane, which can reduce the efficiency of entrapment [15,16]. 
Phospholipids are the main components that form vesicles. The higher 
the phospholipid concentration used, the more vesicles are formed, so 
the absorption of active substances is also expected to be more optimal.
Based on the results of particle size and the calculation of entrapment 
efficiency, F1 was selected as the optimum formula for the cream 
preparations because it had the smallest particle size, with a Z-average 
of 57.76 nm, the smallest polydispersity index value of 0.282, and the 
largest entrapment efficiency of 65.58%.
Table 4: Calibration curve data, LOD, and LOQ of N-acetylcysteine
Concentration (µg/mL) Peak area (µV/s) yi=a+bx S (y/x) LOD (µg/mL) LOQ (µg/mL)
100 284,997 281,332.60 13,427,827.36
200 559,628 565,602.60 35,695,845.16
300 842,068 849,872.60 60,911,781.16 9039.00 9.54 31.80
400 1,147,729 1,134,142.60 184,590,264.96
500 1,420,344 1,418,412.60 3,730,305.96
600 1,697,348 1,702,682.60 28,457,957.16
n=6 ∑=326,813,981.7
LOD: Limit of detection, LOQ: Limit of quantitation
Table 5: Accuracy and precision data of N-acetylcysteine




Recovery (%) Average (%) Standard deviation Coefficient of variation (%)
570,152 201.60 100.80









600 1,722,616 607.01 101.17 100.76 7.9127 1.31
1,690,583 595.74 99.29
Fig. 1: Calibration curve of N-acetylcysteine
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Stability test
Cycling test
The purpose of the cycling test was to determine the physical changes in 
the two creams. After testing for six cycles between 4°C and 40°C±2°C, 
the results showed that neither cream showed a color change nor a 
phase separation. However, the smell of the non-transfersome cream 
had an unpleasant sulfurous odor. Both creams showed good and stable 
results because they did not show phase separation and remained 
homogeneous. However, the transfersome cream was more stable than 
the non-transfersome cream because it did not experience a change in 
odor.
Centrifugal test
The centrifugal test was performed to determine the stability of the 
cream after a very strong shaking after being centrifuged at a speed of 
3750 rpm for 5 h. This speed is equivalent to the gravitational force 
experienced over 1 year. After testing, the two creams did not show 
any separation of the water phase and oil phase, which was probably 
because of the use of appropriate emulsifying agents. In addition, phase 
separation can occur during the stirring process, but an appropriate 
stirring speed was used, which prevented separation during testing. 
Based on these results, we concluded that the two creams could 
withstand the force of gravity for 1 year.
Accelerated stability testing
The accelerated stability testing results are shown in Table 7. The 
curve of accelerated stability testing results of N-acetylcysteine in 
transfersome cream and non-transfersome cream is shown in Fig. 2.
The accelerated stability test was performed to determine the stability 
of the two creams under conditions that can accelerate the change 
in stability at 40°C±2°C and relative humidity of 70% ±5% RH for 
3 months. Storage of cream under accelerated conditions can result in 
a decrease in the level of N-acetylcysteine. This caused the remaining 
N-acetylcysteine levels in the transfersome creams after 3 months to be 
82.92% and non-transfersome creams to be 48.47%.
Decreased levels of N-acetylcysteine in transfersome cream and non-
transfersome cream preparations can occur because of an oxidation 
reaction in N-acetylcysteine compounds. N-acetylcysteine is easily 
oxidized to the disulfide form, N,N-diacetylcysteine [17,18]. The easily 
oxidized group is the thiol/sulfhydryl (-SH) group. Decreasing levels 
in cream preparations can also be caused by other factors, such as the 
presence of water in the cream, the effect of temperature, and the effect 
of humidity under accelerated conditions [19].
Transfersome is a carrier system that is the development of liposomes. 
Transfersomes have almost the same properties as liposomes, but a 
transfersome has a deformability that can increase drug penetration 
through the skin [13]. Transfersome formulations in creams can 
increase the stability of N-acetylcysteine because transfersome vesicles 
can protect the active substance so that contact with oxidizing agents can 
be avoided. In non-transfersome creams, N-acetylcysteine compounds 
are not coated by a vesicle transfersome, so they are easily oxidized. 
This leads to lower N-acetylcysteine levels in non-transfersome creams 
than those in transfersome creams [19].
N-acetylcysteine that has been formulated in the form of transfersomes 
can show decreased levels, similar to those in non-transfersome 
creams. This can be because the entrapment efficiency in the optimum 
transfersome formulation used was 65.58%, so there is still some free 
N-acetylcysteine that can be oxidized as in a non-transfersome cream. 
In addition, decreased N-acetylcysteine levels can also be caused by 
damage to the transfersome vesicles due to the degradation of the lipid 
bilayer as temperature increases. Lipid degradation can also occur 
because of chemical degradation processes that can affect the stability 
of the phospholipid bilayer, such as hydrolysis and lipid oxidation. 
Degradation of the lipid bilayer can reduce the absorption efficiency 
of N-acetylcysteine so that more free N-acetylcysteine is oxidized [15].
Based on the average level of N-acetylcysteine remaining in the two 
cream samples, the shelf life of each cream was calculated using a 
zero-order stability test. Based on the calculated results, the shelf life 
of transfersome cream N-acetylcysteine was 3 months 10 days, and 
the shelf life of non-transfersome cream N-acetylcysteine was 1 month 
2 days. Based on these results, we concluded that the transfersome 
formulation in the preparation of anti-aging cream N-acetylcysteine 
can increase the stability of N-acetylcysteine in anti-aging cream 
preparations.
Antioxidant activity test using DPPH assay
DPPH is a stable free radical compound that has one free electron on 
its nitrogen atom. This test is based on the principle that DPPH accepts 
hydrogen atoms (H) from antioxidant molecules, which results in 
a more stable DPPH-H reduced form. The purple color in the DPPH 







F1 57.76 0.282 65.58
F2 62.62 0.349 62.19
F3 102.4 0.385 59.72
Table 7: Accelerated stability testing results
Sample Average remaining level of N-acetylcysteine (%)
Transfersome cream Non-transfersome cream
Month 0 99.67 99.69
Month 1 94.71 86.06
Month 2 85.31 52.97
Month 3 82.92 48.47
Fig. 2: The curve of accelerated stability testing results of N-acetylcysteine in transfersome cream and non-transfersome cream
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solution will turn yellow as electrons are captured by DPPH, which 
indicates an increase in the reduced form of DPPH-H [20-23].
The maximum DPPH wavelength was 515 nm and was used to measure 
the antioxidant activity of the sample. The half-maximal inhibitory 
concentration (IC50) of N-acetylcysteine was 26.90 µg/mL in transfersome 
cream and 38.63 µg/mL in non-transfersome cream. A compound is said 
to have very strong antioxidant activity if the IC50 is <10 µg/mL, strong 
if it is between 10 and 50 µg/mL, moderate if it is between 50 and 
100 µg/mL, weak if it is between 100 and 250 µg/mL, and not active if 
it is >250 µg/mL [24]. Based on the results obtained, N-acetylcysteine in 
the transfersome and non-transfersome creams had strong antioxidant 
activity because the IC50 was between 10 and 50 µg/mL [24]. The IC50 
value is the concentration of antioxidant compounds needed to inhibit 
50% of existing DPPH activities. Smaller IC50 values have a stronger 
potential for antioxidant activity in these compounds. N-acetylcysteine 
is an antioxidant derived from the amino acid L-cysteine, in which the 
group that is an antioxidant is a thiol/sulfhydryl group (-SH) [3].
The DPPH method antioxidant activity test results of anti-aging cream 
N-acetylcysteine are shown in Table 8.
Franz diffusion cells in vitro penetration test
In vitro penetration tests have two main parameters: The cumulative 
amount of penetrated active substances (µg/cm2) and penetration rate 
(flux) [8,25,26]. Based on the results obtained after 8 h of sampling, the 
cumulative amount of N-acetylcysteine penetrated was greater in the 
transfersome cream (7355.13 µg/cm2) than in the non-transfersome 
cream (4677.61 µg/cm2). In addition, the flux values obtained from 
the slope taken from the linear curve at steady state were based on 
Fick’s First Law. Flux values in the steady-state were higher for the 
transfersome cream preparations (845.67 µg/cm2∙h) than for the non-
transfersome N-acetylcysteine creams (533.33 µg/cm2∙h). These results 
prove that the penetration rates of N-acetylcysteine were faster from 
the transfersome cream preparations than from the N-acetylcysteine 
non-transfersome cream.
The results of the penetration tests performed on the transfersome creams 
and N-acetylcysteine non-transfersome creams showed a significant 
difference. Formulating N-acetylcysteine into a transfersome cream 
increased the cumulative amount and in vitro flux of N-acetylcysteine 
in anti-aging creams relative to those of the non-transfersome creams. 
In the transfersome creams, vesicular transfersomes act as penetration 
enhancers because the vesicles enter the stratum corneum and then 
modify the intracellular lipid lamellae. Transfersome vesicles facilitate 
penetration of N-acetylcysteine through the lipid bilayer membrane of 
the skin stratum corneum, which has pores smaller than the size of the 
drug itself. In addition, phospholipids have a high affinity for biological 
membranes, so incorporation of phospholipid bilayer vesicles with 
intracellular lipid layers onto the skin through a cream can contribute 
to increased permeability of transfersome [9,16,27].
The antioxidant activity results of anti-aging cream N-acetylcysteine 
are shown in Table 9. The cumulative amount of N-acetylcysteine 
penetrated and flux from N-acetylcysteine transfersome and non-
transfersome cream preparations are shown in Fig. 3.
CONCLUSION
The optimum HPLC analysis conditions for analyzing N-acetylcysteine 
compounds in anti-aging creams were identified and found to be 
suitable for future analyses. The optimum transfersome formulation 
used in the anti-aging cream N-acetylcysteine preparations had an 
entrapment efficiency of 65.58%, a particle size of 57.76 nm, and a 
polydispersity index of 0.282. Based on the results of the stability 
test, N-acetylcysteine was more stable in transfersome cream than 
in non-transfersome cream. The average N-acetylcysteine content 
remaining after accelerated stability testing for 3 months was 82.92% 
with a shelf life of 3 months 10 days in the transfersome cream and 
was 48.47% with a shelf life of 1 month 2 days in the non-transfersome 
cream. In addition, physical stability was relatively better in the 
N-acetylcysteine transfersome creams than in the non-transfersome 
creams, as shown by the cycling test and centrifugal test results because 
there was no change in odor as observed for the non-transfersome 
creams. Future studies should attempt to identify substances that 
may be formed as a result of the degradation of N-acetylcysteine in 
anti-aging creams formulated using transfersomes.
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